CDER Issues Guidance Agenda for 2022 Featuring Clinical Trials
March 31, 2022
The FDA’s Center for Drug Evaluation and Research’s (CDER) guidance agenda for 2022 includes eight draft guidances for clinical trials the center hopes to release before the end of the year.